Improving socio-economic outcomes for persons with dementia and informal caregivers
Issued by European Commission · via EU Funding & Tenders Portal
- Published
- 2 Mar 2027
- Closes
- 4 May 2027
- Reference
- HORIZON-CL2-2027-02-TWO-STAGE
- Location
- European Union
- Sector
- Healthcare & Pharma
Details
Expected Outcome:
Projects should contribute to all of the following expected outcomes:
- Persons with dementia experience improved social, mental and socio-economic outcomes through the development and implementation of person-centred interventions that enhance autonomy, inclusion, and quality of life.
- Informal caregivers benefit from reduced emotional, financial, and physical burden thanks to evidence-based support measures, policies, and services that improve their well-being and economic resilience.
- Support networks, long-term care and healthcare systems provide more integrated and accessible care for people with dementia and their caregivers through strengthened coordination between healthcare providers, long-term care and social services, and community organisations.
- Researchers (including from SSH disciplines) and policymakers have access to improved, gender-sensitive data on dementia care to inform policies (in particular national strategies and EU aging policy), optimise resource allocation, and enhance the effectiveness of care models.
Scope:
Dementia is a progressive neurological disease. The number of people with dementia will double by 2050 in the European Union, from 10 million currently. As people with dementia lose their ability to care for themselves, care is often provided by informal caregivers, which mostly include family members, and more specifically women. In fact, 71% of the estimated time devoted to unpaid care for people with dementia is devoted by women. Women, especially those in vulnerable situations such as those from lower socio-economic backgrounds, often face additional pressures in managing caregiving responsibilities, which may exacerbate pre-existing inequalities. Furthermore, the provision of informal care has a negative impact on the economic and social life of the caregiver, as the time spent on the person with dementia is time not spent in employment or with other friends and family. Additionally, informal care is unpaid and has been estimated to have negative financial consequences for the caregivers themselves and the society as a whole. Studies have also shown that people with dementia and their informal caregivers have higher rates of depression than the general population. While there is a lot of attention for clinical research, there is far less attention for the aspects surrounding the economic and social life, financial stability and the mental health of persons with dementia and informal caregivers. Many innovative solutions have been proposed, but few have been implemented on a wide scale. Social public policies with different design and funding that take into account the substitution and complementarities between formal and informal caregivers have been implemented to reduce the burden of the informal caregivers. What is needed, are systemic interventions focussed on improving these aspects for patients and informal caregivers and addressing the gendered nature of caregiving. Priority should be given to scaling up and contextualising interventions that have already shown promise or effectiveness at smaller scale, rather than developing entirely new or untested solutions. Applicants should provide a robust methodological framework for evaluating the effectiveness of the interventions. Proposals should also assess the economic feasibility and sustainability of the interventions, including cost-effectiveness and potential integration into existing health and social care systems or policy frameworks. Proposals can focus on groups in vulnerable situations (e.g. migrants, lower socio-economic populations, people with disabilities) for gender-responsive and inclusive interventions. Social inequality analyses are therefore also recommended. Community based models (e.g. dementia-friendly cities, peer-support groups) can be included, as well as analyses of the quality of residence of people with dementia. Proposals are encouraged to include technology and digital tools in the scope of their work. Considering the already high burden of dementia, interventions should be implemented in at least four Member States or Associated Countries. Considering the focus, it is of the upmost importance that informal caregivers are involved in the research throughout (in the design and implementation) to ensure that interventions are tailored to the real needs of caregivers and the individuals they care for. Proposals should outline clear, evidence-based strategies for tailoring, deploying, and assessing these interventions at individual, family, community, and societal levels, while addressing the specific needs of different caregiver demographics.
Type of action: HORIZON Research and Innovation Actions
Programme period: 2021 - 2027
Priorities: SocietalEngagement, AI, SSH, DigitalAgenda, SocInnov
"> General conditions
1. Admissibility Conditions: Proposal page limit and layout
Applicants submitting a proposal for a blind evaluation (see General Annex F) must not disclose their organisation names, acronyms, logos nor names of personnel in the proposal abstract and Part B of their first-stage application (see General Annex E).
As described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible Countries
As described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide .
3. Other Eligible Conditions
As described in Annex B of the Work Programme General Annexes.
4. Financial and operational capacity and exclusion
As described in Annex C of the Work Programme General Annexes.
5a. Evaluation and award: Award criteria, scoring and thresholds
The first-stage proposals of this topic will be evaluated blindly.
In addition, as described in Annex D of the Work Programme General Annexes.
5b. Evaluation and award: Submission and evaluation processes
As described in Annex F of the Work Programme General Annexes and the Online Manual .
5c. Evaluation and award: I
Context for bidders
We hold 67 notices from European Commission, going back to August 2026 — 67 of them still open. They buy mostly in Healthcare & Pharma, Financial & Professional Services and Water & Environment. There is 1 open Healthcare & Pharma tender in European Union. This one closes in 238 days.
More from this buyer
- Support for dissemination events in the field of Transport Research· closes 7 Oct
- Advancing bio-printing of living cells for regenerative medicine· closes 22 Sept
- Засилване на участието на благотворителните организации в екосистемите за иновации· closes 15 Sept
- Докторантски мрежи „Мария Склодовска-Кюри“ 2027 г.· closes 23 Nov
- Impact of in-kind benefits on income distribution and on vulnerable populations· closes 23 Sept
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- 郑州卫生健康职业学院2026教学设备采购项目-公开招标公告郑州卫生健康职业学院 · China
- 江苏省第一荣军优抚医院医疗辅助服务项目采购公告江苏省复员退伍军人精神病医院 · China
- Supply of Medicines to Cantonment General Hospital, WellingtonDirectorate General Defence Estates · Principal Directorate Defence Estates- Southern Command Pune · Cantonment Board Wellington- SC Pune · India
- 漳州市第二中医院关于“漳州市龙海区医共体资源共享中心和共享中药房建设项目”服务器货物类采购项目(二次)公开招标招标公告漳州市第二中医院 · China
- 无锡市卫生健康综合服务中心关于2026年无锡市C臂机批量集中采购暨江苏省2025年县域医共体设备更新配置项目采购公告无锡市卫生健康委员会 · China
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →